Menu Back toLS13: Let's Think Together about Patient Engagement from the Research Stage of Drug Discovery

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

LS13: Let's Think Together about Patient Engagement from the Research Stage of Drug Discovery

Session Chair(s)

Naomi  Sakurai

Naomi Sakurai

  • Representative Director
  • Canser Solutions, Co., LTD., Japan

Speaker(s)

Fumihiko  Okada, PhD

Fumihiko Okada, PhD

  • Associate Director, Development Regulatory Affairs Department
  • Daiichi Sankyo Co., Ltd., Japan
Rie  Kunisada

Rie Kunisada

  • Associate Director, Neuroscience Drug Discovery Unit
  • Takeda Pharmaceutical Company Limited, Japan

Contact us